Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
We have recently succeeded in producing transgenic mice carrying a hybrid gene consisting of mouse metallothionein promoter-enhancer and the ret oncogene (MT/ret). (Iwamoto et al., 1991b). A retroperitoneal tumour developed in one of 17 MT/ret transgenic founder mice. Histological analysis revealed...
Main Authors: | Iwamoto, T., Taniguchi, M., Wajjwalku, W., Nakashima, I., Takahashi, M. |
---|---|
Format: | Online |
Language: | English |
Published: |
1993
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968281/ |
Similar Items
-
Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in E mu/ret transgenic mice.
by: Ichihara, M., et al.
Published: (1995) -
Identification and characterization of RET fusions in advanced colorectal cancer
by: Le Rolle, Anne-France, et al.
Published: (2015) -
RET Fusion Genes in Korean Non-Small Cell Lung Cancer
by: Yoo, Seung Soo, et al.
Published: (2013) -
Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells
by: Angrisano, T., et al.
Published: (2011) -
The human metallothionein gene family: structure and expression.
by: Karin, M, et al.
Published: (1984)